[HTML][HTML] Clinical neurophysiology of Parkinson's disease and parkinsonism

R Chen, A Berardelli, A Bhattacharya… - Clinical neurophysiology …, 2022 - Elsevier
This review is part of the series on the clinical neurophysiology of movement disorders. It
focuses on Parkinson's disease and parkinsonism. The topics covered include the …

Neuroplasticity in levodopa-induced dyskinesias: an overview on pathophysiology and therapeutic targets

F Bove, B Angeloni, P Sanginario, PM Rossini… - Progress in …, 2024 - Elsevier
Levodopa-induced dyskinesias (LIDs) are a common complication in patients with
Parkinson's disease (PD). A complex cascade of electrophysiological and molecular events …

Plasticity‐Induced Effects of Theta Burst Transcranial Ultrasound Stimulation in Parkinson's Disease

T Grippe, Y Shamli‐Oghli, G Darmani… - Movement …, 2024 - Wiley Online Library
Background Low‐intensity transcranial ultrasound stimulation (TUS) is a noninvasive brain
stimulation (NIBS) technique with high spatial specificity. Previous studies showed that TUS …

[HTML][HTML] The Role of Non-Invasive Brain Modulation in Identifying Disease Biomarkers for Diagnostic and Therapeutic Purposes in Parkinsonism

D Birreci, M De Riggi, D Costa, L Angelini… - Brain Sciences, 2024 - mdpi.com
Over the past three decades, substantial advancements have occurred in non-invasive brain
stimulation (NIBS). These developments encompass various non-invasive techniques aimed …

Assessing the interaction between L‐dopa and γ‐transcranial alternating current stimulation effects on primary motor cortex plasticity in Parkinson's disease

A Guerra, V D'Onofrio, F Asci, F Ferreri… - European Journal of …, 2023 - Wiley Online Library
L‐dopa variably influences transcranial magnetic stimulation (TMS) parameters of motor
cortex (M1) excitability and plasticity in Parkinson's disease (PD). In patients OFF …

Dystonia, chorea, hemiballismus and other dyskinesias

M Bologna, J Valls-Solè, N Kamble, PK Pal… - Clinical …, 2022 - Elsevier
Hyperkinesias are heterogeneous involuntary movements that significantly differ in terms of
clinical and semeiological manifestations, including rhythm, regularity, speed, duration, and …

Monoamine-oxidase type B inhibitors and cognitive functions in Parkinson's disease: beyond the primary mechanism of action

D Rinaldi, M Alborghetti, E Bianchini… - Current …, 2023 - benthamdirect.com
Symptoms of cognitive impairment are rather common since the early stage of Parkinson's
disease (PD); they aggravate with disease progression and may lead to dementia in a …

[HTML][HTML] Functional motor network abnormalities associated with levodopa-induced dyskinesia in Parkinson's disease: A systematic review

BLC Thomsen, MC Vinding, D Meder, L Marner… - NeuroImage: Clinical, 2024 - Elsevier
Parkinson's disease (PD) can be effectively treated with levodopa and dopamine agonists
but leads to levodopa-induced dyskinesia (LID) in most patients in the long run. Various …

Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson's disease: post-hoc analysis of a Japanese phase III study

N Hattori, T Kamei, T Ishida, I Suzuki, M Nomoto… - Journal of Neural …, 2022 - Springer
This post-hoc analysis investigated the long-term effects of safinamide on the course of
dyskinesia and efficacy outcomes using data from a phase III, open-label 52-week study of …

Impaired long-term potentiation-like motor cortical plasticity in progressive supranuclear palsy

M Honda, T Shimizu, S Moriyasu, T Murakami… - Clinical …, 2023 - Elsevier
Objective To elucidate long-term potentiation (LTP)-like effects on the primary motor cortical
(M1) in progressive supranuclear palsy (PSP) and its relationships with clinical features …